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Abstract
Matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS) allows a fast and reliable bacterial identiﬁ-
cation from culture plates. Direct analysis of clinical samples may increase its usefulness in samples in which a fast identiﬁcation of
microorganisms can guide empirical treatment, such as blood cultures (BC). Three hundred and thirty BC, reported as positive by the
automated BC incubation device, were processed by conventional methods for BC processing, and by a fast method based on direct
MALDI-TOF MS. Three hundred and eighteen of them yield growth on culture plates, and 12 were false positive. The MALDI-TOF MS-
based method reported that no peaks were found, or the absence of a reliable identiﬁcation proﬁle, in all these false positive BC. No
mixed cultures were found. Among these 318 BC, we isolated 61 Gram-negatives (GN), 239 Gram-positives (GP) and 18 fungi. Micro-
organism identiﬁcations in GN were coincident with conventional identiﬁcation, at the species level, in 83.3% of BC and, at the genus
level, in 96.6%. In GP, identiﬁcations were coincident with conventional identiﬁcation in 31.8% of BC at the species level, and in 64.8%
at the genus level. Fungaemia was not reliably detected by MALDI-TOF. In 18 BC positive for Candida species (eight C. albicans, nine
C. parapsilosis and one C. tropicalis), no microorganisms were identiﬁed at the species level, and only one (5.6%) was detected at the
genus level. The results of the present study show that this fast, MALDI-TOF MS-based method allows bacterial identiﬁcation directly
from presumptively positive BC in a short time (<30 min), with a high accuracy, especially when GN bacteria are involved.
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Introduction
Some 250 000 patients develop bacteraemia or fungaemia
every year in the USA [1], and the trend towards an increas-
ing incidence and a sustained, high mortality is apparent.
Bloodstream infection pathogen (BSI)-associated mortality in
the USA has been estimated to be 16–40% [2]. Early and
appropriate empirical antimicrobial therapy is essential for
survival of patients with sepsis [3–5]. Attributable mortality
is approximately 20% for BSI patients treated with appropri-
ate empirical therapy, and 34% for patients treated with inap-
propriate empirical therapy [3].
Methods allowing fast and reliable microorganism identiﬁ-
cation, directly from the positive blood culture (BC) bottle,
would be decisive to guide empirical treatment. Several
methods have been assayed to reduce the time to microbial
species identiﬁcation from the BC index [6–10].
Matrix-assisted laser-desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS) has been suggested as
a fast and reliable method for bacterial identiﬁcation from
plate cultures [11], based on protein proﬁles characteristic
for each organism.
Direct analysis of clinical samples may further increase the
usefulness of this method because it can shorten the time
for identiﬁcation of microorganism. In the present study, we
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compared the conventional methods for BSI pathogen identi-
ﬁcation in microbiology laboratories and a fast method based
on conventional detection of positive bottles plus MALDI-
TOF MS directly on the BC.
Materials and Methods
Blood culture processing and biochemical identiﬁcation
We analyzed 330 consecutive, nonselected BCs submitted to
the microbiology laboratory, and reported as positive by the
BC incubation device (BD Bactec 9000; Becton-Dickinson,
Franklin Lajes, NJ, USA).
Eight millilitres of blood, obtained by vein puncture asepti-
cally, were inoculated in BACTEC Plus + Aerobic/F bottles
(Becton-Dickinson), and incubated at 37C in a BACTEC
9240 device (Becton-Dickinson), until they were reported as
positive by the incubation device, or for a maximum of
10 days. No speciﬁc anaerobic bottles were used. For sam-
ples reported by the BACTEC 9240 as presumptively positive,
a Gram stain was performed, and 100 lL were cultured onto
blood agar, chocolate, McConkey and Sabouraud agar plates.
Plates were incubated in aerobic atmosphere with 10% CO2,
at 37C for 18–24 h. Negative plates were incubated for an
additional 48 h and, if they remained negative, were dis-
carded. When there was colonies growth, microorganisms
were identiﬁed by conventional methods [WIDER MIC/ID
Gram-positives and WIDER MIC/ID Gram-negatives (manu-
factured for Francisco Soria Melguizo SA, Madrid (Spain) by
MicroScan, Sacramento, CA, USA) for bacteria, and Auxacol-
or 2 (Bio-Rad, Marnes-la-Coquette, France) for fungi].
MALDI-TOF MS
Sample preparation for MALDI-TOF. Four millilitres of BC were
centrifuged at 2000 g for 30 s to remove leucocytes. Superna-
tant was centrifuged at 15 500 g for 5 min to collect bacteria.
The pellet was washed once with deionized water. Then, an
ethanol/formic acid extraction procedure was applied: a small
amount of bacteria was resuspended in 300 lL of water. Later,
900 lL of absolute ethanol was added and the mixture was
centrifuged at 15 500 g for 2 min, and the supernatant was
discarded. Fifty microlitres of formic acid (70% v/v) was added
to the pellet and mixed thoroughly before the addition of 50 lL
of acetonitrile. The mixture was centrifuged again at 15 500 g
for 2 min. One microlitre of the supernatant was placed onto a
spot of the steel card and air-dried at room temperature.
The supernatant was overlaid with 1 lL of matrix solution
[saturated solution of HCCA (a-cyano-4-hydroxy cinnamic
acid) in organic solvent (50% acetonitrile and 2.5% triﬂuoro-
acetic acid)] and air-dried.
MALDI-TOF MS. Measurements were performed in an Auto-
ﬂex III MALDI-TOF/TOF mass spectrometer (Bruker Dalton-
ics, Leipzig, Germany) equipped with a 200-Hz smartbeam
laser. Spectra were recorded in the linear, positive mode at
a laser frequency of 200 Hz within a mass range from 2000–
20 000 Da. The IS1 voltage was 20 kV, the IS2 voltage was
maintained at 18.6 kV, lens voltage was 6 kV and the extrac-
tion delay time was 40 ns.
For each spectrum, 500 laser shots were collected and
analyzed (10 · 50 laser shots from different positions of the
target spot). The spectra were externally calibrated using the
standard calibrant mixture (Escherichia coli extracts including
the additional proteins RNase A and myoglobin; Bruker
Daltonics). Calibration masses were: RL36, 4364.3 Da; RS22,
5095.8 Da; RL34, 5380.4 Da; RL33meth, 6254.4 Da, RL32,
6315 Da; RL29, 7273.5 Da; RS19, 10299.1 Da; RNase A,
13682.2 Da; myoglobin, 16952.5 Da.
Data analysis. For automated data analysis, raw spectra were
processed using the MALDI BIOTYPER, version 2.0, software
(Bruker Daltonics) with default settings. The software per-
forms normalization, smoothing, baseline substraction and
peak picking, creating a list of the most signiﬁcant peaks of
the spectrum (m/z values with a given intensity, with the
threshold set to a minimum of 1% of the highest peak and a
maximum of 100 peaks). To identify unknown bacteria, every
peak list generated was matched directly against reference
libraries (3290 species) using the integrated patterns match-
ing algorithm of BIOTYPER, version 2.0 (Bruker Daltonics). The
unknown spectra were compared with a library of reference
spectra based on a pattern recognition algorithm using peak
position, peak intensity distributions and peak frequencies.
Results scoring. MALDI-TOF identiﬁcations were classiﬁed
using modiﬁed score values proposed by the manufacturer: a
score ‡2 indicated species identiﬁcation, a score in the range
1.7–1.9 indicated genus identiﬁcation, and a score <1.7 indi-
cated no identiﬁcation.
Sequence data
When MALDI-TOF reported a reliable identiﬁcation at the
genus or species level, and it was different to conventional
identiﬁcation, this identiﬁcation was conﬁrmed by PCR for
16S RNA [12].
Results
Three hundred and thirty BCs reported as positive by the
BACTEC 9240 device were processed both by plate culture
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and conventional biochemical identiﬁcation, and by MALDI-
TOF MS. Twelve samples (3.6%) reported as positive by the
BACTEC 9240 device were negative in culture. All of them
were reported as revealing no reliable identiﬁcation or no
peaks found by the MALDI-TOF MS.
Three hundred and eighteen samples led to growth of
one colony morphology in culture. No mixed cultures were
found. The identiﬁcation is shown in Table 1. MALDI-TOF
MS and conventional methods reported the same identiﬁca-
tion for Enterobacteriaceae, at the species level, in 43 of 48
BC bottles (89.6%), and at the genus level in 47 of 48 bottles
(97.9%). Nonfermentative Gram-negative bacilli were identi-
ﬁed at the species level in eight of 12 bottles (66.7%), and
at the genus level in 100%. As a whole, correlation in BCs
TABLE 1. Identiﬁcation by matrix-
assisted laser desorption/ionization
time-of-ﬂight mass spectrometry
(MALDI-TOF MS) and conventional
identiﬁcation of 318 microorgan-
isms isolated from blood cultures
Conventional
identiﬁcation
(number of isolates)
Correlation
at the species
level (%)
Correlation
at the genus
level (%)
MALDI-TOF
identiﬁcation
(number of isolates)
Acinetobacter baumanii (2) 50 100 Acinetobacter baumanii (1)
Acinetobacter sp. (1)
Bacillus fusiformis (1) – 100 Bacillus sp. (1)
Candida albicans (8) – – No reliable ID (8)
Candida parapsilosis (9) – 11.1 Candida sp. (1)
No reliable ID (7)
No peaks found (1)
Candida tropicalis (1) – – No reliable ID (1)
Corynebacterium amycolatum (1) – – No reliable ID (1)
Enterobacter amnigenus (1) – – No reliable ID (1)
Enterobacter spp. (1) – 100 Enterobacter hormaechei (1)
Enterococcus faecalis (14) 78.6 78.6 Enterococcus faecalis (11)
No reliable ID (3)
Enterococcus faecium (3) 33.3 66.7 Enterococcus faecium (1)
Enterococcus sp. (1)
No reliable ID (1)
Escherichia coli (29) 96.5 100 Escherichia coli (28)
Escherichia sp. (1)
Francisella tularensis (1) – – No reliable ID (1)
Klebsiella oxytoca (4) 100 100 Klebsiella oxytoca (4)
Klebsiella pneumoniae (6) 83.3 100 Klebsiella pneumoniae (5)
Klebsiella oxytoca (1)
Listeria monocytogenes (1) 100 100 Listeria monocytogenes (1)
Morganella morganii (1) 100 100 Morganella morganii (1)
Proteus mirabilis (2) 100 100 Proteus mirabilis (2)
Pseudomonas aeruginosa (8) 87.5 100 Pseudomonas aeruginosa (7)
Pseudomonas sp. (1)
Pseudomonas ﬂuorescens (1) – 100 Pseudomonas mosselii (1)
Pseudomonas putida (1) – 100 Pseudomonas monteilii (1)
Salmonella spp. (2) 100 100 Salmonella spp. (2)
Serratia marcescens (2) 50 100 Serratia marcescens (1)
Serratia sp. (1)
Staphylococcus aureus (36) 5.5 30.5 Staphylococcus aureus (2)
Staphylococcus sp.(9)
Enterococcus sp. (2)
No reliable ID (23)
Staphylococcus auricularis (3) – – No reliable ID (3)
Staphylococcus capitis (6) 16.7 100 Staphylococcus capitis (1)
Staphylococcus sp.(5)
Staphylococcus epidermidis (93) 26.9 69.9 Staphylococcus epidermidis (25)
Staphylococcus hominis (2)
Staphylococcus sp.(38)
No reliable ID (25)
No peaks found (3)
Staphylococcus haemolyticus (11) 36.4 54.5 Staphylococcus haemolyticus (4)
Staphylococcus sp.(2)
No reliable ID (5)
Staphylococcus hominis (53) 43.4 79.2 Staphylococcus hominis (23)
Staphylococcus lugdunensis (2)
Staphylococcus sp.(17)
No reliable ID (10)
No peaks found (1)
Staphylococcus simulans (3) 33.3 33.3 Staphylococcus simulans (1)
Staphylococcus sp.(1)
No reliable ID (1)
Staphylococcus warneri (2) 50 100 Staphylococcus warneri (1)
Staphylococcus sp.(1)
Streptococcus agalactiae (3) 66.7 100 Streptococcus agalactiae (2)
Streptococcus gallolyticus (1)
Streptococcus mutans (2) – – No reliable ID (2)
Streptococcus pneumoniae (1) 100 100 Streptococcus pneumoniae (1)
Streptococcus pyogenes (3) 66.7 66.7 Streptococcus pyogenes (2)
No reliable ID (1)
Streptococcus spp. (3) – – No reliable ID (3)
Total Gram-negative 83.3 96.6
Total Gram-positive 31.8 64.8
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positive for Gram-negative bacteria was 85% at the species
level, and 98.3% at the genus level. In the only enterobacteria
in which identiﬁcation was considered to have failed, there
was correlation at the genus species (Enterobacter amnigenus
in conventional identiﬁcation vs. Enterobacter asburiae in
MALDI-TOF), but MALDI-TOF identiﬁcation was considered
to have failed because the score was <1.7.
The only BC positive for Francisella tularensis could not be
identiﬁed by MALDI-TOF MS, because no peptide proﬁles
for this species are included in the BIOTYPER database.
Only three Gram-positive bacilli (one Listeria monocytoge-
nes, one Bacillus fusiformis, one Corynebacterium amycolatum)
were studied because their presence in BCs is unusual.
There was correlation at the species level for L. monocyto-
genes, at the genus level for B. fusiformis (MALDI-TOF from
the BC bottle also reported B. fusiformis, but the score was
<1.9), and identiﬁcation was considered to have failed for
C. amycolatum. MALDI-TOF reported C. amycolatum too, but
the score was <1.7, and thus was considered unreliable.
Enterococci were identiﬁed at the species level in 12 of 17
BCs (70.6%), and at the genus level in 13 of 17 BCs (76.5%).
Streptococci were identiﬁed in 50% of BCs, both at the
species and genus levels. The highest failure rate was for
Streptococcus mutans and Streptococcus spp. (100% failures).
Two of three Streptococcus agalactiae, two of three Strepto-
coccus pyogenes and the only Streptococcus pneumoniae found
were correctly identiﬁed at the species level.
Coagulase negative staphylococci (CNS) showed frequent
misidentiﬁcation at the species level (67.8%), although the
correlation at the genus level was higher (123/171; 71.9%). In
48 BCs, CNS grew on plate, but MALDI-TOF identiﬁcation
failed. Twenty-three of them were reported as revealing no
reliable identiﬁcation (14 bottles) or no peaks found (9
bottles). In 25 BCs, identiﬁcation was considered to have
failed because the MALDI-TOF score was <1.7, although the
species reported with the highest score was always a CNS.
MALDI-TOF reliability for Staphylococcus aureus direct
identiﬁcation was low. Only two of 36 isolates (5.6%) were
correctly identiﬁed at the species level, and 11 of 36 isolates
(30.6%) at the genus level. Two isolates were incorrectly
identiﬁed as enterococci, and 20 BCs (55.6%) from which
S. aureus was isolated by conventional methods,
were reported by MALDI-TOF MS as revealing no reliable
identiﬁcation.
Current score values accepted (>2 for species identiﬁca-
tion and >1.7 for genus identiﬁcation) guarantee excellent
identiﬁcation speciﬁcity. Nevertheless, lower values may
remain reliable at the genus level. Thirty-one out of 33
(93.9%) Gram-positives with scores in the range 1.5–1.7
(24/25 Staphylococcus, 2/2 Enterococcus, 4/5 Streptococcus and
1/1 Corynebacterium) reported the same identiﬁcation as con-
ventional methods at the genus level. Therefore, we consider
those values must be taken into account because they
improve Gram-positive genus identiﬁcation by 12% (Table 2).
Fungaemia was not reliably detected by MALDI-TOF MS.
Among 18 BCs positive for Candida species, only one (5.6%)
was reported correctly at the genus level, whereas, for the
other 17 BCs (eight C. albicans, eight C. parapsilosis and one
C. tropicalis), MALDI-TOF reported no reliable identiﬁcation
(16 bottles) or no peaks found (one bottle).
When the ﬁndings of MALDI-TOF MS and biochemical
identiﬁcation disagreed, 16S rDNA sequencing was per-
formed, conﬁrming the MALDI-TOF MS results in most
cases (Table 3).
Discussion
BC processing has improved signiﬁcantly since the ﬁrst semi-
automated systems were developed in the 1970s, with
newer, automated, continuous monitoring systems. Never-
theless, alternative methods for early identiﬁcation in positive
BCs are expensive, and have not reached a wide diffusion so
far. In most cases, bacteria growing in BC remain to be iden-
tiﬁed through subculture on agar plates from BC bottles,
directly or after centrifugation, overnight incubation and
identiﬁcation of colonies by rapid or conventional bio-
chemical tests or, in some cases, by ﬂuorescence or in situ
TABLE 2. Identiﬁcation by matrix-
assisted laser desorption/ionization
time-of-ﬂight mass spectrometry of
Gram-positive isolates from blood
culture at different identiﬁcation
levels with different scores limits
Microorganism
Identiﬁcation level
Species
(score >2)
Genus
(score 1.7–2)
Genus
(score <1.7)
Gram-positive Streptococci 6/12 (50%) 6/12 (50%) 10/12 (83.3%)
Enterococci 12/17 (70.6%) 13/17 (76.5%) 15/17 (88.2%)
Staphylococci 57/207 (27.5%) 134/207 (64.7%) 158/207 (76.3%)
Bacillus 0/1 (0%) 1/1 (100%) 1/1 (100%)
Listeria 1/1 (100%) 1/1 (100%) 1/1 (100%)
Corynebacterium 0/1 (0%) 0/1 (0%) 1/1 (100%)
Total 76/239 (31.8%) 155/239 (64.8%) 186/239 (77.8%)
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hybridization [6–10]. This methodology delays bacterial iden-
tiﬁcation for several hours, or even days when fastidious bac-
teria or bacteria requiring complementary tests for
identiﬁcation are involved.
MALDI-TOF MS has been reported as a powerful
resource for bacterial identiﬁcation from conventional cul-
ture [11]. Previous studies suggest an excellent correlation
between MALDI-TOF MS and conventional microbiological
identiﬁcation in bacterial and fungal clinical isolates [12–16].
Direct analysis of clinical samples might increase the useful-
ness of MALDI-TOF MS because it might allow clinically use-
ful results earlier than conventional procedures. MALDI-TOF
MS direct bacterial identiﬁcation from positive BC bottles
might allow an early species- or genus-oriented empirical
treatment. Some studies [17,18] suggest that mortality is 70%
lower in patients receiving appropriate empirical treatment.
The use of MALDI-TOF MS directly on clinical samples
might have some theoretical limitations (high organisms den-
sity required to obtain a good protein proﬁle, interference
of human or culture broth proteins in bacterial signature).
Nevertheless, studies of MALDI-TOF MS reliability for direct
microbial identiﬁcation in urine specimens study are promis-
ing [19]. Recent studies on BCs suggest that this might apply
also for BCs [20–22].
The results of the present study show that MALDI-TOF
MS allows excellent identiﬁcation, at the species level, for all
the enterobacteria studied, and at the genus level for all the
Gram-negatives tested, excepting F. tularensis because protein
proﬁles are not available in the BIOTYPER database. Recent
studies also show excellent results for Gram-negatives, with
correct identiﬁcation rates >90% [12,16]. When we found
any discrepancy, 16S RNA PCR conﬁrmed MALDI-TOF iden-
tiﬁcation in most cases (Table 3). According to previous
studies, even 16S rDNA sequencing is not always able to dif-
ferentiate some Pseudomonas species such as Pseudomonas
monteilii and Pseudomonas putida [12]. This happened in the
present study for one BC, where P. putida was identiﬁed by
conventional identiﬁcation methods and P. monteilii by
MALDI-TOF MS, and 16S rDNA sequencing did not differen-
tiate both species.
It is already described that MALDI-TOF MS identiﬁcation
reliability for Gram-positives is lower than for Gram-
negatives in BCs. Stevenson et al. [20], among 14 BCs
positive for S. aureus, reported scores <1.7 in two cases
(14.3%) and scores in the range 1.7–1.9 in three cases
(21.4%). In nine BCs, S. aureus was identiﬁed correctly
(64.3%). La Scola et al. [21] identiﬁed correctly S. aureus in
40–58% of cases, depending on the protocol used. In the
present study only two out of 36 S. aureus were identiﬁed at
the species level (5.5%), and 11 out of 36 (30.6%) at the
genus level. Moreover, we obtained two misidentiﬁcations at
the genus level (Enterococcus spp. instead of Staphylococcus).
As a whole, the present study identiﬁed correctly 55 out
of 171 CNS (32.2%) at the species level, and 123 out of 171
(71.9%) at the genus level. Stevenson et al. [20] identiﬁed, at
the species level, 25 out of 42 BCs with CNS (59.5%), and
33 out of 42 (78.6%) with a score of 1.7–1.9. La Scola et al.
[21] identiﬁed 38–93% of CNS depending on the protocol
used, and a recent study using ammonium chloride to break
erythrocytes membranes identiﬁed 26.1% of S. epidermidis at
the species level, and 82.6% at the genus level [22].
Nevertheless, if we consider correct identiﬁcations at the
genus level with a score >1.5 instead of >1.7, 158 out of 207
Staphylococci BCs were correctly identiﬁed at the genus level
(76.3%), increasing the genus identiﬁcations in 11.6%.
In the case of streptococci, we have identiﬁed correctly
the 50% by MALDI-TOF MS. The global identiﬁcation pro-
portion is similar to other studies (40.9%). Nevertheless, if
we consider scores >1.5 for genus identiﬁcation, among the
three major pathogens included in the present study
(S. pneumoniae, S. pyogenes and S. agalactiae), ﬁve out of six
BCs (83.3%) were correctly identiﬁed.
We have found no previous studies on MALDI-TOF MS
usefulness for detecting fungaemia in BC. The results of the
present study show that MALDI-TOF MS, at least with the
protocol used, is not a reliable method for detecting funga-
emia. In 18 fungaemia episodes, MALDI-TOF MS detected
the microorganism in only one BC at the species level. Prob-
able new protocols will be developed in the near future for
improving MALDI-TOF reliability in these cases. Indeed, a
TABLE 3. Comparison between
conventional identiﬁcation, matrix-
assisted laser desorption/ionization
time-of-ﬂight mass spectrometry
(MALDI-TOF MS) and 16S RNA
PCR in identiﬁcation discrepancies
Conventional
identiﬁcation MALDI-TOF report (score)
16S RNA PCR
identiﬁcation
Acinetobacter baumanii Acinetobacter spp (score >2) Acinetobacter baumanii
Enterobacter spp. Enterobacter hormaechei (score >2) Enterobacter hormaechei
Klebsiella pneumoniae Klebsiella oxytoca (score >2) Klebsiella oxytoca
Pseudomonas ﬂuorescens Pseudomonas mosselii (score >2) Pseudomonas mosselii
Pseudomonas putida Pseudomonas monteilii (score >2) Pseudomonas monteilii/putida
Staphylococcus aureus Enterococcus faecalis (score 1.7–1.9) Staphylococcus aureus
Staphylococcus aureus Enterococcus faecium (score 1.7–1.9) Staphylococcus aureus
Staphylococcus epidermidis
(3 isolates)
Staphylococcus hominis (score >2) Staphylococcus hominis
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recent study [23] reports a new method for detecting inva-
sive fungal infection with good results, although that study
was performed with simulated BCs and must be conﬁrmed
with real BCs.
In summary, MALDI-TOF MS is a fast and reliable tech-
nique for bacterial identiﬁcation in BCs isolates. Gram-nega-
tive bacteria were identiﬁed at the genus level with scores
>1.7 in 96.6% of cases, and Gram-positives in 64.8%. More-
over, considering correct genus identiﬁcation with scores
>1.5 for Gram-positives, the proportion reaches 77.8%.
Thus, we state that MALDI-TOF MS is an elegible meth-
odology in the clinical setting for straightforward bacterial
identiﬁcation from positive BCs. The identiﬁcation of invasive
fungi directly from BCs is still unsatisfactory, and requires
further technical development.
This fast and high accurate technology might allow an
early genus-oriented clinical treatment, reducing identiﬁca-
tion time, costs in laboratory reagents and most likely
patient mortality.
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